Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.560
-0.030 (-1.16%)
At close: Oct 2, 2026, 4:00 PM EDT
2.610
+0.050 (1.95%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Rocket Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Rocket Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $8.85. The average 1-year stock price forecast is 245.70% higher than the current stock price, while the lowest is $3.00 (+17.19%) and the highest is $15 (+485.94%).
Price Target: $8.85 (+245.70%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rocket Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 6 | 6 | 6 | 6 | 6 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2026 |
| Needham | Needham | Buy Upgrades $9 | Buy | Upgrades | $9 | +251.56% | Sep 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $10 | Buy | Maintains | $10 | +290.62% | Sep 16, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $12 | Buy | Maintains | $12 | +368.75% | Sep 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $15 | Buy | Maintains | $15 | +485.94% | Sep 15, 2026 |
Financial Forecast
Revenue This Year
1.11M
Revenue Next Year
11.25M
from 1.11M
Increased by 915.60%
EPS This Year
-0.11
from -1.98
EPS Next Year
-1.30
from -0.11
EPS and Forward PE are based on non-GAAP adjusted numbers.